The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.60
Bid: 27.60
Ask: 27.90
Change: -0.30 (-1.08%)
Spread: 0.30 (1.087%)
Open: 27.05
High: 28.30
Low: 27.05
Prev. Close: 27.90
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chairman

6 Sep 2018 07:00

RNS Number : 9098Z
Marston's PLC
06 September 2018
 

 

 

 

 

 

6 September 2018

MARSTON'S PLC

 

APPOINTMENT OF CHAIRMAN

 

 

Marston's PLC is pleased to announce the appointment of William Rucker as Chairman with effect from 1 October 2018.

 

William Rucker is Chief Executive of Lazard in the UK, the NYSE-listed investment bank that is one of the world's pre-eminent financial advisory and asset management firms.

 

William started his career at Arthur Andersen where he qualified as an accountant. He joined Lazard in 1987, working in the Corporate Finance Group across a broad range of industry sectors with particular expertise in leisure, lodging, real estate and retail. He became Chief Executive of Lazard London in 2004.

 

William is also currently Chairman of the UK Dementia Research Institute (UK DRI) and a Committee Member of Cheltenham Racecourse.

 

Previously, he was Chairman of Crest Nicholson PLC from 2011 until March 2018; Chairman of Quintain Estates and Development plc from 2009 until 2015; and a Non Executive Director of Rentokil Initial plc from 2008 until 2013.

 

Commenting, Ralph Findlay, Chief Executive Officer of Marston's, said:

'We are delighted to welcome William Rucker to the Board of Marston's as our Chairman and look forward to working with him. William brings with him extensive expertise, having advised a broad range of companies and chaired two publicly quoted companies. His skillset will further strengthen our existing Board and add significant value in helping Marston's to deliver its future growth ambitions."

 

Commenting, William Rucker, said:

"Marston's is a well-respected business and a leader in its field which is well placed to capitalise on current sector trends with a leading beer business, a balanced, well invested pub portfolio and growing lodge accommodation business. I look forward to working with the Board and wider executive management team to maximise the future opportunities open to the Group going forward."

 

There are no other details that are required to be disclosed in respect of William Rucker's appointment under Rule 9.6.13 of the Listing Rules of the UK Listing Authority.

 

 

ENQUIRIES:

Marston's PLC

Instinctif Partners

Ralph Findlay, Chief Executive Officer

Justine Warren

Andrew Andrea, Chief Financial Officer

Matthew Smallwood

Tel: 01902 329516

Tel: 0207 457 2020

 

 

 

NOTES TO EDITORS

Marston's is a leading pub operator and independent brewer.

It has an estate of 1,568 pubs situated nationally, comprising managed, franchised and leased pubs.

It is the UK's leading brewer of premium cask and packaged ales, including Marston's Pedigree, Wainwright, Lancaster Bomber and Hobgoblin. The beer portfolio also includes Banks's, Jennings, Wychwood, Ringwood, Brakspear and Mansfield beers. Following the acquisition of CWBB, Marston's has added Bombardier, Courage and McEwan's to its brand portfolio most recently, as well as a range of licensed brands including Young's, Founders and Estrella Damm.

Marston's employs around 14,500 people.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABLGDCSBGBGIU
Date   Source Headline
28th Mar 20242:50 pmRNSDirector/PDMR Shareholding
15th Mar 202410:15 amRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSSuccession plan to appoint new Chair of the Board
7th Mar 202410:03 amRNSDirector Declaration
6th Mar 20248:35 amRNSDirector/PDMR Shareholding
5th Mar 20244:24 pmRNSDirector/PDMR Shareholding
1st Mar 202412:58 pmRNSTotal Voting Rights
9th Feb 20248:40 amRNSHolding(s) in Company
7th Feb 20244:08 pmRNSHolding(s) in Company
2nd Feb 202411:14 amRNSDirector/PDMR Shareholding
1st Feb 20244:26 pmRNSHolding(s) in Company
31st Jan 20241:52 pmRNSHolding(s) in Company
23rd Jan 20241:30 pmRNSResult of AGM
23rd Jan 20247:00 amRNSTrading for the 16-week period to 20 January 2024
9th Jan 20241:57 pmRNSBlock listing Interim Review
20th Dec 20234:16 pmRNSAnnual Financial Report
5th Dec 20237:00 amRNSPRELIMINARY RESULTS
1st Dec 20232:30 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSDirectorate Change
22nd Nov 20232:02 pmRNSHolding(s) in Company
17th Nov 20237:00 amRNSMarston’s PLC appoints Justin Platt as new CEO
11th Oct 20237:00 amRNSTrading update for the 52 weeks to 30 Sep 2023
15th Aug 20233:36 pmRNSHolding(s) in Company
1st Aug 20239:30 amRNSHolding(s) in Company
26th Jul 20234:29 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSTrading update for the 42 weeks to 22 July 2023
10th Jul 20233:21 pmRNSBlock listing Interim Review
4th Jul 20232:18 pmRNSNotification of Trading Update Date
29th Jun 202310:26 amRNSDirector/PDMR Shareholding
28th Jun 20235:03 pmRNSDirector/PDMR Shareholding
28th Jun 20234:54 pmRNSDirector/PDMR Shareholding
27th Jun 20234:11 pmRNSDirector/PDMR Shareholding
26th Jun 20232:23 pmRNSDirector/PDMR Shareholding
26th Jun 20231:08 pmRNSDirector/PDMR Shareholding
25th May 20238:16 amRNSDirector/PDMR Shareholding
24th May 20238:48 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 1 APRIL 2023
31st Mar 20237:00 amRNSAmendment and extension of debt facilities
22nd Mar 202310:19 amRNSHolding(s) in Company
24th Jan 20232:01 pmRNSResult of AGM
24th Jan 20237:00 amRNSTrading for the 16-week period to 21 January 2023
10th Jan 20233:07 pmRNSBlock listing Interim Review
6th Jan 20233:11 pmRNSHolding(s) in Company
3rd Jan 20239:42 amRNSHolding(s) in Company
21st Dec 20225:05 pmRNSConfirmation of Covenant Amendments
21st Dec 20222:34 pmRNSAnnual Financial Report
14th Dec 20229:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSPreliminary Results for 52 weeks ended 1 Oct 2022
5th Dec 202212:31 pmRNSConfirmation of Final Results announcement date
30th Nov 202210:46 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.